BPI East is next week! Hope to see you there – don’t miss these great talks and activities!
BPI East 2017 begins September 25th in Boston. The conference is focused on providing companies the opportunity to share ideas, strategies and solutions to overcome challenges at every stage of development. Cell Culture Dish/Downstream Column will be attending and blogging from the event. Please don’t miss our BPI East related blogs over the next month.
If you are attending, don’t miss these exciting talks and activities!
Interesting Talks in Each Track. Here are some examples:
Keynote Presentations
A Vision for Rare Disease: How We Can Champion Underserved Patients
Flemming Ornskov, M.D., MPH, Chief Executive Officer, Shire
Synthetic Biology: Biomedical Applications Come of Age
James Collins, Ph.D., Termeer Professor of Medical Engineering & Science and Professor, Department of Biological Engineering at Massachusetts Institute of Technology
Tools for Mapping and Repairing Disease States: Can We Make Therapeutic Invention into a Mature Design Science?
Ed Boyden, Ph.D., Termeer Associate Professor, Media Lab and McGovern Institute Departments of Biological Engineering and Brain and Cognitive Sciences at Massachusetts Institute of Technology
Genomics, Advanced Imaging and the Future of Medicine
J. Craig Venter, Ph.D., Co-Founder, Executive Chairman, Head of Scientific Strategy at Human Longevity, Inc.
The Convergence Model of Cancer Research: Solving the Problems of Cancer through Interdisciplinary Approaches
Tyler Jacks, Ph.D., Director, Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology
Building Value Through External Stakeholder Engagement
Liz Lewis, Chief Counsel and Head of Patient Advocacy at Takeda Oncology
Networking Opportunities:
Tuesday
Celebration of Science Networking Reception – Exhibit Hall 5:15
Kick off your conference experience at the Opening NightParty to celebrate the launch of Biotech Week Boston! Explore our “Celebration of Science” theme with a taste of molecular gastronomy from Boston’s celebrity chefs. Participate in several interactive activities and/or relax in one of the themed lounge areas. Enjoy a fun evening with food, drinks and entertainment.
Hosted by:
Wednesday
Battle of the Biotech Bands – 6:30
A community-driven, networking event with fundraising efforts supporting the charitable foundation affiliated with each biotech band. Already in its fourth year, the Battle of the Biotech Bands is a unique and fun experience now open to both BPI and BWB attendees.
*Limited number of spaces available. Please reserve your space when you register.
Cell Culture Dish and Downstream Column Sponsor Activities:
BD Biosciences – Booth 620
Beckman Coulter – Booth 227
Bio-Ess Laboratories, LLC – Booth 423
See new data on Cell-Ess universal titer boost presented by CSO Dr. Adam Elhofy at Posters:
-
- Glycolytic Complexity and Pattern Consistency can be Improved by Using a Novel Supplement and Feed – Poster #C33
-
Novel Approach to Production of Influenza in Minimal to No Serum – co-published with FujiFilm Poster #C32
Cell Culture Company– Booth 426
Charter Medical – Booth 1229
Talk: Dominic Clarke, Ph.D., Global Product Manager, Charter Medical will be a panelist on Tuesday, September 26th at 2:15
PANEL DISCUSSION: We Need to Talk about Particulates, Leachables and Extractables
- Discussing strategies used for the identification and control of particulates, leachables and extractables
- Evaluating the need for new technologies, methods and strategies
- Addressing particulates, leachables and extractables given a lack of regulatory guidance / specifications
- Assessing the importance come the clinic
Corning – Booth 411
Corning is announcing their new collagen dissolvable microcarriers, a revolutionary advancement in cell expansion technology.
Technology Workshop:
John Huyhn, Ph.D., Director of Clinical Manufacturing at the University of Pennsylvania, will describe his approach for successfully scaling AAV production for Gene Therapy on September 27 at 12:00 p.m.
Finesse – Booth 526
Fujifilm Diosynth Biotechnologies – Booth 910
Talks:
Wednesday September 27th at 1:30, BPI Theatre
The Saturn mAb Platform: High Throughput Monoclonal Antibody Development and Manufacturing
Dr. Patrick Robertson, Director Program Design
Fujifilm’s Saturn Platform offers de-risked, rapid and reliable development and cGMP manufacturing for mAbs. The platform encompasses process assessment, analytical development and manufacturing using dedicated facilities with standardized equipment, raw materials and consumables to which increases efficiency and reduces cost, lead times and risk. Saturn programs can start with Fujifilm’s Apollo s cell line or with client cell lines.
Wednesday September 27th at 3:00
Comparison of adherent cell technologies for the amplification of virus stocks and viral vectors
Dr. Steve Pincus, Associate Vice President, Virology & Analytical Methods Development
The production of high titer viral vectors for large scale vaccine production affords many challenges. Often it is difficult translation to make mammalian adherent cells from small laboratory scale to the much larger manufacturing scale. In this study we examine several of the available technologies for their ability to support adherent cell growth as well as virus production. The parameters we evaluated in this study include cell growth, virus production, infectious virus and virus yield per cell.
GE Healthcare Life Sciences – Booth 207
Preconference symposia:
Advanced control strategies in bioprocessing and biomanufacturing: disruptive technologies and emerging platforms for biologics facilities of the future
Mon. Sept. 25 | 9 am
By: Bill Whitford, Strategic Solutions Leader, Cell Culture, Bioprocess, GE Healthcare
Presentations:
Evaluation of next-generation protein A chromatography resin for the purification of monoclonal antibodies
Thu. Sept. 28 | Noon
By: Bryan Dransart, Senior Research Scientist, Gilead Biosciences Recover and purification track
Technical posters:
- Evaluation of ÄKTA™ readyflux for ultrafiltration to high protein concentration
- A next-generation protein A resin for improved productivity and bioburden control
- Characterization of Xcellerex™ single-use bioreactor systems
- Development of a perfusion process with automated control of the biomass
Technology workshops:
Cell culture perfusion doesn’t need to be complicated
Tue. Sept. 26 | 11:50 am
By: Yasser Kehail, Global Bioprocessing and Analytics Product Manager, GE Healthcare
The critical role of automation in CAR T cell manufacturing
Tue. Sept. 26 | 11:50 am
By: Rodney L. Rietze, Process Innovation and Strategic Development, Novartis
Outsourcing process development in the bid to bring rare therapies to clinic faster
Wed. Sept. 27 | 12:05 pm
By: Alex Tracy PhD, VP of Pharmaceutical Development and Manufacturing, Roivant Sciences Inc.
Addressing the risk of bioburden and the need for increased productivity in protein A chromatography
Thu. Sept. 28 | 7:30 am
By: Jonathan Royce, Senior Product Manager, GE Healthcare
Thirty years of mAbs and protein A: a retrospective look at 30 years of synergies
Thu. Sept. 28 | 9:50 am
By: Geoff Hale, Managing Director, Bioarchitech
For more details, please see – BPI Flyer
Irvine Scientific – Booth 1123
Technology Workshops:
Tuesday, 26 September 2017 11:50am – 12:20pm
The Development of Animal-Component-Free, Chemically-Defined Culture Media for Immune Cells
Wednesday, 27 September 2017 12:05pm – 12:35pm
Control Glycosylation and its Functional Impact on Therapeutic Antibody
JSR Life Sciences – Booth 513
Posters:
- Case study of a continuous capture step of a monoclonal antibody downstream process – Kaori Itaya, R&D engineer
- A Novel Chromatographic Technology: Enhancing performance Utilizing a Modular, Lattice Supported Resin Bed – Masayoshi Nagaya, Sr. Global Technology Manager
- New affinity resins for Fab fragment antibodies purification – Takashi Matsuda Ph.D, R&D Manager
- New Protein L Affinity Resins for Antibody Fragments Purification – Masaaki Hanamura Ph.D., R&D Manager
Kaneka – Booth 607
Kerry – Booth 421
MaxCyte – Booth 724
Talk:
Keys to Accelerated Production of the Right Protein from the Right Cells, Presenter: Joan Hilly-Foster
Poster:
Fast Tracking Biotherapeutic Development Using Flow Electroporation Technology for Large-scale Transient Expression, Cell Line Generation and Genome Modification.
MilliporeSigma – Booth 211
Talks:
Innovative Chromatography Technologies to Enable Next Generation Downstream Processing of Monoclonal Antibodies
September 26, 9:15 a.m., Room 306
James G. Stout, Vice President, Natrix Separations
Cell Culture Medium Designed for Perfusion Process: Case Studies and Impact on Upstream Process Economy
September 26, 11:15 – 11:45 a.m., Room 304
Delia Lyons, MSc. Senior Scientist, Head Perfusion Media Development
Virus Safety for Vaccines, Viral Vectors, and Cell Based Therapies
September 26, 11:50 a.m. – 12:20 p.m., Room 204
Damon Asher, Head of MilliporeSigma Americas Vaccine Initiative
Investing in Process Development for Increased MSC Production in Stirred Tank Bioreactors
September 26, 1:45 – 2:15 p.m., Room 210
Julie Murrell, Ph.D., Head of Cell Therapy Bioprocessing
Risk Reduction and Economic Considerations for Implementing Upstream Virus Filtration
September 26, 2:15 – 2:45 p.m., Room 308
Michael Cunningham, Ph.D., Associate Director, Applications Engineering, MSAT
Visit the MilliporeSigma website for more information on activities at BPI.
http://www.emdmillipore.com/bioprocess-international
Molecular Devices – Booth 216
Technology Workshop:
Time: Tuesday, September 26, 11:50am – 12:20pm
A microfluidics-based single cell isolation workflow optimized for efficiency, viability, and assurance of monoclonality
Steve Wiltgen, PhD, Product Manager, Molecular Devices
Poster:
A microfluidics-based single cell isolation workflow optimized for efficiency, viability, and assurance of monoclonality
Nucleus Biologics – Booth 514
Pall Life Sciences – Booth 219 & 319
September 25th
Continuous Processing
9 am: Chairman’s Opening Remarks
(Peter Levison, Ph.D. – Senior Marketing Director, Downstream Processing, Pall Life Sciences)
9:15 am: Perspectives on Continuous Processing
(Howard Levine, Ph.D. – Founder, President and Principal Consultant, BioProcess Technology Consultants)
9:45 am: Pilot-Scale Perfusion and Clarification Using Multidimensional Acoustic Wave Perfusion Device
(William Napoli – Scientist, Bioprocess Technology and Expression, BioProcess Development, Merck & Co., Inc.)
10:45 am: Cadence Acoustic Separator and Implementation Potential for Mammalian Harvest or Continuous Processing
(Daniel LaCasse – Principal Scientist, BioTherapeutics R&D, Purification Process Development, Pfizer)
11:15 am: Approaches to Improving Chromatographic Productivity: Scale Up Evaluation
(Lindsay Arnold – Scientist, BioProcess Engineering, MedImmune)
11:45 am: In-line Diafiltration (ILDF) – A Practical Solution for Continuous Buffer Exchange and Increased Plant Versatility
(Briana Russo, MSc. – Process Development Engineer II, Pre-Clinical Manufacturing & Process Development, Regeneron Pharmaceuticals, Inc.)
1:30 pm: Chairman’s Remarks
(Marc Bisschops, Ph.D. – Senior Principal Scientist, Continuous Processing, Pall Life Sciences)
1:45 pm: Continuous Diafiltration Using Countercurrent Staging
(Andrew Zydney, Ph.D. – Professor and Department Head, Chemical Engineering, The Pennsylvania State University)
2:15 pm: Economic Evaluation of Continuous Downstream Bioprocessing
(Mark Schofield, Ph.D. – Principal R&D Engineer, Pall Life Sciences)
3:15 pm: Panel Discussion: Debottlenecking Batch Processes by Adopting Continuous
(Peter Levison, Ph.D. – Senior Marketing Director, Downstream Processing, Pall Life Sciences)
4 pm: Continuous BioManufacturing: Past, Present, and Future
(Sadettin Ozturk, Ph.D. – SVP, Process and Analytical Development, MassBiologics)
4:30 pm: A Look at Reality: The Short-term Outlook for Continuous Manufacturing of Biologics
(Jeff Odum – Global Technology Partner, Strategic Manufacturing Concept Group, NNE)
September 27th
Viral Safety Track
8:10 am: Viral Safety – Chairperson’s Remarks
(Morven McAlister, Ph.D. – Senior Director, Pall Life Sciences)
8:45 am: Virus Filtration in Continuous Bioprocessing
(Morven McAlister, Ph.D. – Senior Director, Pall Life Sciences)
Cell Culture Recovery and Purification Track
8:15 am: Acoustic Wave Separation as a Novel Clarification Technique for the Removal of Aggregate–Enriched Calcium Phosphate Precipitates During Bispecific Antibody Purification
(Lindsay Arnold – Scientist, BioProcess Engineering, MedImmune)
1:55 pm: Cell Culture & Upstream Processing / Recovery & Purification Shared Session: Case Studies and Lessons Learned
Chairperson’s Remarks
(Peter Levison, Ph.D. – Senior Marketing Director, Downstream Processing, Pall Life Sciences)
3:00 pm: An Update on Significant Technology Advances Enabling Integrated Continuous Bioprocessing
(Michael Egholm, Vice President, Biopharmaceuticals, Pall Life Sciences)
For more information, please visit Pall’s BPI Event website
Purolite – Booth 1323
Praesto ‘Jetted’ Agarose Resins
Discover Purolite Life Sciences’ latest Praesto ‘jetted’ agarose resins. These resins are manufactured to demonstrate enhanced performance characteristics including: better pressure/flow properties, improved resolution, and tighter bead size specifications. For further information or to discuss your purification challenges, come visit booth 1323.
For more information, please see –Purolite BPI Flyer
Roche Custom Biotech – Booth 619 & 1205
Come visit Booth 619 to learn about new products and solutions for Upstream and Downstream Bioprocessing.
Come visit Booth 1205 to learn about new products and solutions for Cell Therapy Manufacturing.
Thermo Fisher Scientific – Booth 911
Vironova – Booth 709
Technology Workshop:
Tuesday, 26 September 2017 11:50am – 12:20pm
Meaningful Insights on Subvisible Particle Morphology, Size and Purity
Electron Microscopy (EM) together with image analysis give unmatched insight on sample purity, particle stability and morphological characteristics. This case study shows how a table-top MiniTEM system developed by Vironova is used to automatically detect undesired process outcome such as debris, broken particles and aggregates. Purity and integrity of AAV and Adenovirus Gene Therapy vectors samples are measured automatically in about one hour.
Mathieu Colomb-Delsuc, Ph.D., Senior Scientist, Electron Microscopy Technologies at Vironova